findmyKOL

Robert Coleman, MD

Enriched profile

Chief Medical Officer, Vaniam Group (inaugural, appointed May 2023); also practicing gynecologic oncologist at Texas Oncology–The Woodlands · Vaniam Group

ORCID↗NPI↗
✓ Full profile
RegionHouston, TX · South CentralSpecialtyGynecologic OncologyFocusOvarian cancer diagnosis and treatment+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Robert Coleman is Chief Medical Officer, Vaniam Group (inaugural, appointed May 2023); also practicing gynecologic oncologist at Texas Oncology–The Woodlands at Vaniam Group. OpenAlex indexes 1,362 publications with 53,393 citations (h-index 105); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Gynecologic Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Robert L. Coleman is Chief Medical Officer, Vaniam Group (inaugural, appointed May 2023). The public record shows 1,362 publications with 53,393 citations (h-index 105), centered on Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments. It also documents an investigator role on 11 registered clinical trials.

  • Most recent indexed publication: 2026 · JCO precision oncology
  • Top research focus: Ovarian cancer diagnosis and treatment
  • 11 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Fallopian Tube Neoplasms4 trialsOvarian / Gynecologic Cancer3 trialsAdenocarcinoma, Clear Cell3 trialsCarcinoma, Transitional Cell2 trialsCarcinoma, Endometrioid2 trialsAdenocarcinoma, Mucinous2 trialsCarcinoma, Ovarian Epithelial2 trialsBrenner Tumor1 trialFibroma1 trialEndometrial Neoplasms1 trialCarcinoma, Adenosquamous1 trialCarcinoma, Squamous Cell1 trialPeritoneal Neoplasms1 trialSarcoma1 trialLeiomyosarcoma1 trialComa1 trialMyosarcoma1 trial

Research focus

OpenAlex concept fingerprint
Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapyEndometrial and Cervical Cancer TreatmentsAngiogenesis and VEGF in CancerIntraperitoneal and Appendiceal Malignancies

Drugs & molecules

across trials, industry payments and publications
Elaheregeneric · Mirvetuximab soravtansineClinical trials1Industry payments14Publications2Avastingeneric · BevacizumabClinical trials1Industry payments2Publications5Lynparzageneric · OlaparibClinical trials—Industry payments32Publications2Rubracageneric · RucaparibClinical trials—Industry payments11Publications7Xpoviogeneric · SelinexorClinical trials—Industry payments12Publications3Tivdakgeneric · TisotumabClinical trials—Industry payments9Publications1Enhertugeneric · TrastuzumabClinical trials—Industry payments8Publications1Zejulageneric · NiraparibClinical trials—Industry payments6Publications1CarboplatinClinical trials3Industry payments—Publications3PaclitaxelClinical trials3Industry payments—Publications3DocetaxelClinical trials3Industry payments—Publications1LetrozoleClinical trials1Industry payments—Publications2

Works with

trial sponsors and companies reporting payments
ImmunoGen, Inc.Clinical trials1Industry payments5Merck Sharp & Dohme LLCClinical trials—Industry payments75GlaxoSmithKline, LLC.Clinical trials—Industry payments54AstraZeneca Pharmaceuticals LPClinical trials—Industry payments40Abbvie Inc.Clinical trials—Industry payments20Seagen Inc.Clinical trials—Industry payments19AstraZeneca UK LimitedClinical trials—Industry payments16Clovis Oncology, Inc.Clinical trials—Industry payments14Eisai Inc.Clinical trials—Industry payments14Karyopharm Therapeutics Inc.Clinical trials—Industry payments12Novocure Inc.Clinical trials—Industry payments12Daiichi Sankyo Inc.Clinical trials—Industry payments9Merck Sharp & Dohme CorporationClinical trials—Industry payments9BioNTech SEClinical trials—Industry payments8Genmab U.S., Inc.Clinical trials—Industry payments8Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments8Alkermes, Inc.Clinical trials—Industry payments7Gilead Sciences, Inc.Clinical trials—Industry payments7Aadi Bioscience, Inc.Clinical trials—Industry payments6National Cancer Institute (NCI)Clinical trials6Industry payments—Corcept TherapeuticsClinical trials—Industry payments5EMD Serono Research & Development Institute, Inc.Clinical trials—Industry payments5E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments4BeOne Medicines USA, Inc.Clinical trials—Industry payments3Genentech, Inc.Clinical trials—Industry payments3Myriad Genetic Laboratories, Inc.Clinical trials—Industry payments3Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Novocure GmbHClinical trials—Industry payments3BeiGene USA, Inc.Clinical trials—Industry payments2Chugai Pharmaceutical Co., Ltd.Clinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,362publications

Distinct works indexed by OpenAlex, matched via ORCID; 48 in PubMed.

53,393citations

Total citations across indexed works.

105h-index

Hirsch index (OpenAlex). i10-index 471.

Clinical & industry

trials, payments and federal funding
16clinical trials

Investigator role on registered studies.

View trials ↓
42companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:

All 16 trial records: search, sort and filter.Explore →

Industry payments

42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 89 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 48 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
    1,870 citations2018
    doi.org ↗
  2. 02
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
    1,705 citations2017
    doi.org ↗
  3. 03
    2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
    1,512 citations2007
    doi.org ↗
  4. 04
    Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
    1,299 citations2006
    doi.org ↗
  5. 05
    Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
    1,201 citations2016
    doi.org ↗
All 1,362 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Anil K. Sood429Alpa M. Nick178Bradley J. Monk166David M. O’Malley155Shannon N. Westin154Gabriel Lopez‐Berestein125Heather J. Dalton119Brian M. Slomovitz109Nicholas B. Jennings105Amit M. Oza101Lingegowda S. Mangala99Ana Oaknin97Behrouz Zand96Rebecca A. Previs95Pamela T. Soliman94Kathleen N. Moore94Sunila Pradeep93Thomas J. Herzog91Michael Frumovitz90David M. Gershenson89Karen H. Lu87Wei Hu85Cristina Ivan84Bryan Fellman78Sherry Y. Wu76Elizabeth M. Swisher76Justin Bottsford-Miller75Pedro T. Ramírez74Carol Aghajanian73Yvonne G. Lin73Chunhua Lu71Domenica Lorusso68William M. Merritt66Iain A. McNeish64Rajesha Rupaimoole63Ignace Vergote63Gordon B. Mills62Whitney A. Spannuth61Lara Maloney61Prahlad T. Ram59

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/robert-coleman-md-73f1f4cb

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/robert-l-coleman-b257b6

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    sciprofiles.com/profile/384030

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sciprofiles.com ↗
  • Other

    onclive.com/authors/robert-coleman-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • ResearchGate

    researchgate.net/lab/Robert-L-Coleman-Lab

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/profile/Robert-Coleman-4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Robert-L-Coleman-2105095746

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    ascopost.com/videos/2018-asco-annual-meeting/robert-coleman-on-ovarian-cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
  • Other

    onclive.com/view/coleman-and-slomovitz-continue-the-discussion-on-maintenance-parp-inhibition-in-ovarian-cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗
  • M.D.

    Creighton University School of Medicine, Omaha, NE

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • Residency

    Obstetrics & Gynecology, Northwestern Medicine Prentice Women's Hospital / Northwestern University Medical Center, Chicago, IL

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • Board certified

    Gynecologic Oncology and Obstetrics/Gynecology; FACOG (Fellow, American College of Obstetricians and Gynecologists)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • FACS (Fellow, American College of Surgeons)
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • FASCO (Fellow, American Society of Clinical Oncology) - noted on Vaniam Group site
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vaniamgroup.com ↗

Editorial & leadership roles

journal and society appointments
  • President

    Society of Gynecologic Oncology (SGO), 2015-2016

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usoncology.com ↗
  • Immediate Past-President

    International Gynecologic Cancer Society (IGCS), 2020-2022

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaniamgroup.com ↗
  • Co-Director

    GOG-Partners (Gynecologic Oncology Group Partners Foundation), and Board of Directors, GOG-Foundation, Inc.

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaniamgroup.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Former Chief Scientific Officer

    US Oncology Research (USOR/USRI), and Chief Medical Officer, Sarah Cannon Research Institute (SCRI), a joint-venture research organization

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usoncology.com ↗
  • Former Vice-Chairman

    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas; former Assistant Professor, Creighton University

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaniamgroup.com ↗
  • Texas Oncology–The Woodlands

    practicing gynecologic oncologist (clinical practice, part of The US Oncology Network)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • Surgical privileges at Memorial Hermann The Woodlands Medical Center
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
  • Former Professor and Ann Rife Cox Chair in Gynecology

    Deputy Chair, Vice-Chair of Clinical Research, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center …

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • Co-Director

    GOG-Partners Foundation, Inc.; Board of Directors, GOG-Foundation, Inc.

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaniamgroup.com ↗
  • Member

    Scientific Advisory Committee, Ovarian Cancer Research Alliance (OCRA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗
  • Scientific/clinical advisor

    Acrivon Therapeutics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acrivon.com ↗
  • Advisory role

    Genelux Corporation

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →genelux.com ↗
  • Scientific Advisor

    Esperance Pharmaceuticals

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
  • Team/advisory role

    Panavance Therapeutics

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →panavance.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.